The University of Chicago Header Logo

Search Results (18)

More Search Options
MatchTypeWhy
Adjuvant aromatase inhibitors: are we there yet?Academic Article Why?
Aromatase inhibitors: an overview for surgeons.Academic Article Why?
The expanding use of third-generation aromatase inhibitors: what the general internist needs to know.Academic Article Why?
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.Academic Article Why?
Aromatase InhibitorsConcept Why?
Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression.Academic Article Why?
Incidence and management of arthralgias in breast cancer patients treated with aromatase inhibitors in an outpatient oncology clinic.Academic Article Why?
Two cases of treatment with aromatase inhibitors and development of miliary osteoma cutis-Is there an association?Academic Article Why?
Adjuvant ovarian suppression in premenopausal breast cancer.Academic Article Why?
Adjuvant ovarian suppression in premenopausal breast cancer.Academic Article Why?
Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials.Academic Article Why?
Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics.Academic Article Why?
Don't Be Fooled by DCIS.Academic Article Why?
Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial.Academic Article Why?
Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors.Academic Article Why?
Per Page    Page  of 2last Nextnext
Prev
Search Criteria
  • Aromatase Inhibitors
Filter by Type
_
Click "Why?" to see why an item matched the search.